Chiasma
1 follower
‌
Chiasma is a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection.
Industries
Headquarters
Employees
Links
Org chart
Raj Kannan
Chief Executive Officer
Raj Kannan
Collapse
Dan Thornton
VP Market Access and Patient Services
David Plante
VP Information Technology
Dawn Schottlandt
VP Investor Relations & Corporate Communications
Derek Brown
VP Marketing
Drew Enamait
VP Finance & Administration
Ethel Koczon
VP Clinical Operations
Gary Patou
Head of Clinical
Joe Lyons
Executive Director Human Resources
Lee Giguere
VP General Counsel
Mark J. Fitzpatrick
President
Scott Mcconnell
VP Medical Affairs
Shoshie Katz
VP Quality Assurance & Regulatory Affairs
William Ludlam
Senior VP Clinical Development and Medical Affairs
Similar companies
Synthekine
3 followers
Forge Biologics
2 followers
Expansion Therapeutics
2 followers
Kyverna Therapeutics
5 followers
Caribou Biosciences
1 follower
Neuron23
1 follower
Slingshot Biosciences
1 follower
Odyssey Therapeutics
2 followers
Cellares
2 followers
Astria Therapeutics
1 follower
Thermo Fisher Scientific
149 followers
Discover companies